Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Mayer WJ, Wolf A, Kernt M, Kook D, Kampik A, Ulbig M et al. Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion. Eye 2013; 27 (7): 816–822.
Pardo-López D, Francés-Muñoz E, Gallego-Pinazo R, Díaz-Llopis M . Anterior chamber migration of dexametasone intravitreal implant (Ozurdex®). Graefes Arch Clin Exp Ophthalmol 2012; 250 (11): 1703–1704.
Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J et alOZURDEX GENEVA Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010; 117 (6): 1134–1146.e3.
Acknowledgements
All the authors conceived and designed the work that led to the submission, acquired data, playing an important role in interpreting the results, drafted the manuscript and approved the final version.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Hernández-Martínez, P., Gallego-Pinazo, R., Martínez-Castillo, S. et al. Local safety of repeated intravitreal Ozurdex. Eye 28, 361–362 (2014). https://doi.org/10.1038/eye.2013.265
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2013.265
This article is cited by
-
Response to Hernández-Martínez et al
Eye (2014)
